The disordered N-terminal tail of the neuropeptide Y Y2 receptor makes fleeting contacts with NPY that prolong binding and selectively control arrestin-3 recruitment without affecting G protein signaling.
40 cross-links mappedCross-linking mass spectrometry captured 40 transient contact points between NPY and the disordered Y2 receptor tail, revealing a signaling bias mechanism
What the researchers found
Cross-linking mass spectrometry captured 40 contact points between a photo-reactive NPY analog and the intrinsically disordered N-terminus (NT) of the Y2 receptor. Molecular dynamics simulations revealed that these contacts are rapid and transient, with the structurally flexible NT constantly interconverting between conformations.
Mutagenesis of electrostatic hotspots in the NT showed that these residues control the conformational ensemble of the disordered region. Functionally, the transient NT-NPY contacts prolong ligand residence time at the receptor, which is specifically required for efficient recruitment of arrestin-3 but not for Gi protein coupling. This establishes a mechanism by which the disordered N-terminus selectively biases receptor signaling toward arrestin pathways.
Why it matters
Most drug design targeting GPCRs focuses on the transmembrane binding pocket, ignoring the flexible N-terminus. This study shows that the disordered tail is not just structural decoration — it actively controls which signaling pathways are activated. This has major implications for designing 'biased' peptide drugs that selectively activate beneficial pathways (like G protein signaling) while avoiding problematic ones (like arrestin-mediated desensitization), potentially leading to more effective peptide therapeutics with fewer side effects.
How the study worked
Researchers used a photo-reactive NPY analogue combined with cross-linking mass spectrometry (XL-MS) to capture transient interactions between NPY and the Y2R N-terminus that are invisible to conventional structural methods. The resulting 40 cross-links provided distance constraints for building structural models. Molecular dynamics simulations explored the conformational dynamics of the interaction. Site-directed mutagenesis of key Y2R residues, followed by functional assays for Gi protein and arrestin-3 recruitment, established the signaling consequences of disrupting NT-ligand contacts.
What this study cannot tell us
The study was conducted primarily in vitro and in silico, without in vivo validation of the functional consequences. Cross-linking mass spectrometry captures snapshots of interactions that may not fully represent the dynamic reality. The mutagenesis experiments alter the receptor permanently, which differs from the transient modulation that might occur naturally. The findings are specific to the Y2R-NPY interaction and may not generalize to all peptide GPCRs, though the authors propose this as a broader mechanism.
How to read the evidence
This is a rigorous structural and functional study published in Nature Communications, combining multiple advanced techniques (XL-MS, molecular dynamics, mutagenesis, functional assays). The evidence is strong for the molecular mechanism described, though it lacks in vivo validation and generalization to other receptor systems.
When this study was published
Published in 2025, this is a very recent study at the cutting edge of GPCR structural biology and biased signaling research.
The bigger picture
Biased agonism — designing drugs that activate one signaling pathway over another — is one of the hottest areas in pharmacology. This study reveals that intrinsically disordered receptor regions, previously considered too floppy to matter, actually serve as signaling bias switches. Since about one-third of the human genome encodes GPCRs and many are peptide receptors with disordered N-termini, this mechanism could be widespread and exploitable for drug design across many therapeutic areas.
Questions still open
- Do other peptide GPCRs use disordered N-termini to control signaling bias, and is this a general mechanism across the receptor family?
- Could peptide drugs be designed to specifically exploit or bypass NT-mediated arrestin recruitment for therapeutic advantage?
- How do post-translational modifications of the disordered N-terminus (such as glycosylation or phosphorylation) affect its role in biased signaling?
Common questions
What does 'intrinsically disordered' mean for a receptor, and why does it matter?
What is biased signaling and why is it important for drug design?
Read the original research
Transient ligand contacts of the intrinsically disordered N-terminus of neuropeptide Y2 receptor regulate arrestin-3 recruitment.
Nature communications, 16(1), 8326
Citation
Kaiser, Anette; Rojas Echeverri, Juan C; Baischew, Asat; Pankonin, Maik; Leitner, Karl D; Iacobucci, Claudio; Sala, Davide; Ihling, Christian; Müller, Ronny; Ferenc, Rok; Beck-Sickinger, Annette G; Schmidt, Peter; Meiler, Jens; Hildebrand, Peter W; Sinz, Andrea. (2025). Transient ligand contacts of the intrinsically disordered N-terminus of neuropeptide Y2 receptor regulate arrestin-3 recruitment.. Nature communications, 16(1), 8326. https://doi.org/10.1038/s41467-025-64051-4